DrugDashboards
← Home
Manufacturing facility

Simtra Deutschland GmbH

A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.

Country
Germany
Registered address
Kantstrasse 2, Halle/Westfalen, 33790, Germany (DEU)
Operations here
analysisapi manufacturelabelmanufacturepackparticle size reductionsterilize
FDA identifiers
FEI 3002806419 · DUNS 344276063

Recent inspection flagged official action

FDA classified an inspection here as OAI (official action indicated) within the last two years — the strongest public warning signal a facility gets. This plant is listed on labels for 9 drugs. A supply problem here can ripple to all of them.

FDA inspection history

Outcomes of closed FDA inspections at this site (drug and biologic program areas).

  • OAIDrug Quality Assurance2025-09-26
  • NAIDrug Quality Assurance2023-05-03
  • VAIDrug Quality Assurance2020-01-29
  • NAIDrug Quality Assurance2019-09-03
  • VAIDrug Quality Assurance2018-06-14
  • VAIDrug Quality Assurance2017-06-27
  • VAIDrug Quality Assurance2016-03-18
  • NAIDrug Quality Assurance2014-07-01
  • NAIDrug Quality Assurance2013-07-20
  • NAIDrug Quality Assurance2011-08-26
  • NAIDrug Quality Assurance2010-07-22

Drugs this plant is listed as making

9 distinct drugs across 13 products name this site in their FDA label.

Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.